ETF comparison
Verified factor-similar pair

FTA vs SPVM

These US-listed equity ETFs share verified FF6 US factor exposure. The modeled volatility of their factor-return difference is at or below 3% annualized on both the same 36-month window and a longer factor-history check.

HML
Current similarity score
88
Factor-similar

The score is 100 for identical fitted exposures and 80 at the 3% modeled tracking-error limit. It includes market and non-market factors; it does not indicate which fund earned or is expected to earn more. How to read this score.

Quick Read

  • SPVM has the higher backtested relative Sharpe (1.051 vs 0.770).
  • SPVM has the lower published fee (0.51% vs 0.58%).
  • FTA is cheaper on dividend valuation (98 vs 110, where 100 is each fund's historical median).
  • FTA has the stronger regression fit (adjusted R-squared 0.936 vs 0.907).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

FTA

First Trust Large Cap Value AlphaDEX Fund
HML RMW UMD
Adj. R2
0.936
Rel. Sharpe
0.770
Mkt beta
0.78
AUM
US$1.3B
MER
0.58%
Valuation
98

SPVM

Invesco S&P 500 Value with Momentum ETF
HML
Adj. R2
0.907
Rel. Sharpe
1.051
Mkt beta
0.83
AUM
US$116M
MER
0.51%
Valuation
110

Market beta uses the common 36-month window through 2026-08. Adjusted R² and relative Sharpe describe each fund's separately published full-history model.

Factor Exposure Match

Blue bars compare factor beta magnitude from the same 36 months shown above. Green bars compare absolute t-stat strength; dim bars indicate |t| below 1.96. Every factor enters the distance calculation regardless of its t-statistic.

SMB
FTA
+0.19
|t|
+1.7
SPVM
+0.16
|t|
+1.2
diff +0.03
HML
FTA
+0.50
|t|
+3.8
SPVM
+0.54
|t|
+3.5
diff -0.04
RMW
FTA
+0.14
|t|
+1.5
SPVM
+0.21
|t|
+2.0
diff -0.07
CMA
FTA
+0.31
|t|
+2.1
SPVM
+0.18
|t|
+1.1
diff +0.13
UMD
FTA
-0.09
|t|
-1.2
SPVM
+0.02
|t|
+0.2
diff -0.11

What Happened Over the Same 36 Months

FTA adjusted total-return CAGR
17.36%
SPVM adjusted total-return CAGR
18.90%

SPVM ahead by 1.55 percentage points/year over 2023-09 through 2026-08. This is the observed difference between annualized compounded returns from adjusted prices, not an expected return or a factor-model estimate.

Historical factor attribution

Signed contribution to FTA minus SPVM, percentage points/year, using fitted 36-month exposures and average factor returns over those same months:

Market factor
-0.69
Other factors, combined
-1.03
Total factor-implied difference
-1.72

This arithmetic-average factor attribution excludes the regression intercept and fund-specific return. It therefore need not equal the observed CAGR difference and is not a forecast.

Why This Pair Matches

Modeled factor tracking error · 36m
1.85%/yr
Modeled tracking error · 120m factor history
1.76%/yr
Mkt beta diff
0.04
Rel. Sharpe diff
0.281

Fitted exposures and factor covariance estimate the volatility, not the average or direction, of the funds' modeled return difference. The common regression window is 2023-09 through 2026-08. A short-window estimate and a longer factor-history check must both be at or below 3.000%; this is a screening limit, not a forecast. Holdings, turnover, taxes and trading costs require a separate review. The Sharpe figures elsewhere on this page come from each fund's published full-history model and do not enter similarity ranking. See the full methodology.

FTA fund page SPVM fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.